First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized treatment ...
Transcranial magnetic stimulation (TMS) has proven to be a promising tool for research, diagnosis, and treatment of neurodegenerative diseases and psychiatric disorders such as depression, ...
MALVERN, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results